Core Viewpoint - PetMed Express, Inc. has announced the resignation of its CEO Sandra Campos and CFO Robyn D'Elia, leading to interim leadership changes as the company searches for new executives [1][2]. Leadership Changes - Leslie C.G. Campbell, Chair of the Board, has taken on the role of Interim CEO, while Douglas Krulik, Chief Accounting Officer, is now the Interim Principal Financial Officer [2]. - The company is actively seeking candidates for both the CEO and CFO positions [2]. Separation Agreements - Both Campos and D'Elia have entered into separation agreements that include severance payments equivalent to their current base salary for thirteen months and accelerated vesting of some unvested restricted stock units [3]. - They will also provide consulting services to the company for three months on an as-needed basis [3]. Board of Directors Adjustments - Following Campos's resignation, she also stepped down from the Board of Directors, reducing the board size to five members [4]. - Campbell will remain as Chair of the Board but will resign from the Audit Committee and the Compensation and Human Capital Committee [4]. - Justin Mennen has been appointed as Lead Independent Director, with Peter Batushansky and Leah Solivan taking over as Chairs of the Audit Committee and Compensation and Human Capital Committee, respectively [4]. Company Overview - PetMed Express, Inc. is a pioneer in the direct-to-consumer pet healthcare sector, offering a wide range of pet health solutions, including pharmaceuticals and OTC supplements [5]. - The company is licensed across all 50 states and aims to support pet wellness through its online pharmacy services [5].

Core Viewpoint - PetMed Express, Inc. has received a notice from Nasdaq regarding non-compliance with listing rules due to the late filing of its Annual Report on Form 10-K for the fiscal year ending March 31, 2025 [1][3]. Group 1: Compliance and Filing Status - The notice indicates that the company must submit a plan to regain compliance within 60 days, by September 1, 2025, and may receive an extension of up to 180 days to regain compliance [3]. - The company filed a Notification of Late Filing on Form 12b-25, stating it was unable to file the Form 10-K on time due to ongoing efforts to compile and analyze necessary financial information [3][4]. - The company is working diligently to complete its financial statements and plans to file the Form 10-K as soon as possible to regain compliance with Nasdaq listing rules [4]. Group 2: Company Overview - PetMed Express, Inc. is a pioneer in the direct-to-consumer pet healthcare sector, operating as a national online pharmacy licensed across all 50 states [5]. - The company offers a comprehensive range of pet health solutions, including pharmaceuticals, compounded medications, and OTC supplements, focusing on value, convenience, and care for pet wellness [5].